Search Within

Surgery

  1. "Future Medicine"
Formats
  1. Journal Article (24)
  2. Review (2)
  3. Book Section (1)
Groups
  1. Urology (5)
  2. Department of Medicine (4)
  3. Epidemiology and Biostatistics (4)
  4. Population Sciences Research Program (4)
  5. Solid Tumor Oncology Division (4)
  6. GDMT, Surgery (3)

More Groups

People
  1. Prasad Adusumilli (3)
  2. Shahrokh Shariat (3)
  3. Babak Mehrara (2)
  4. Dennis Chi (2)
  5. Evan Weitman (2)
  6. Ian Ganly (2)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2019 (3)
  4. 2017 (2)
  5. 2016 (3)
  6. 2015 (2)

More Years

Publications
  1. Future Oncology (12)
  2. Immunotherapy (4)
  3. Personalized Medicine (2)
  4. Aging Health (1)
  5. Biomarkers in Medicine (1)
  6. Clinical Practice (1)

More Publications

Publishers
  1. Future Medicine (27)

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • MATTERHORN: Phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer
    Review

    Janjigian, Y. Y.; Van Cutsem, E.; Muro, K.; Wainberg, Z.; Al-Batran, S. E.; Hyung, W. J.; Molena, D.; Marcovitz, M.; Ruscica, D.; Robbins, S. H.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden
    Journal Article

    Peterfy, C.; Chen, Y.; Countryman, P.; Chmielowski, B.; Anthony, S. P.; Healey, J. H.; Wainberg, Z. A.; Cohn, A. L.; Shapiro, G. I.; Keedy, V. L.; more...
    Future Oncology (2022)

    Fulltext@MSK | Save
  • Clinician perspectives on communication and implementation challenges in precision oncology
    Journal Article

    Hamilton, J. G.; Banerjee, S. C.; Carlsson, S. V.; Vera, J.; Lynch, K. A.; Sar-Graycar, L.; Martin, C. M.; Parker, P. A.; Hay, J. L.
    Personalized Medicine (2021)

    Fulltext@MSK | Save
  • Clinical outcomes in men with prostate cancer who selected active surveillance using a clinical cell cycle risk score
    Journal Article

    Kaul, S.; Wojno, K. J.; Stone, S.; Evans, B.; Bernhisel, R.; Meek, S.; D'Anna, R. E.; Ferguson, J.; Glaser, J.; Morgan, T. M.; more...
    Personalized Medicine (2019)

    Fulltext@MSK | Save
  • Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1)
    Journal Article

    Perez, M. C.; Zager, J. S.; Amatruda, T.; Conry, R.; Ariyan, C.; Desais, A.; Kirkwood, J. M.; Treichel, S.; Cohan, D.; Raskin, L.
    Melanoma Management (2019)

    Fulltext@MSK | Save
  • KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer
    Review

    Bang, Y. J.; Van Cutsem, E.; Fuchs, C. S.; Ohtsu, A.; Tabernero, J.; Ilson, D. H.; Hyung, W. J.; Strong, V. E.; Goetze, T. O.; Yoshikawa, T.; more...
    Future Oncology (2019)

    Fulltext@MSK | Save
  • Chemotherapy-induced immunomodulation in non-small-cell lung cancer: A rationale for combination chemoimmunotherapy
    Journal Article

    Zheng, H.; Zeltsman, M.; Zauderer, M. G.; Eguchi, T.; Vaghjiani, R. G.; Adusumilli, P. S.
    Immunotherapy (2017)

    Fulltext@MSK | Save
  • Surgical salvage of recurrence after resection of colorectal liver metastases: Incidence and outcomes
    Journal Article

    Rahbari, N. N.; D'Angelica, M. I.
    Hepatic Oncology (2017)

    Fulltext@MSK | Save
  • A peripheral blood biomarker estimates probability of survival: The neutrophil-lymphocyte ratio in noncancer patients
    Journal Article

    Davis, J. L.; Moutinho, V. Jr; Panageas, K. S.; Coit, D. G.
    Biomarkers in Medicine (2016)

    Fulltext@MSK | Save
  • A regional approach for CAR T-cell therapy for mesothelioma: From mouse models to clinical trial
    Journal Article

    Mayor, M.; Zeltsman, M.; McGee, E.; Adusumilli, P. S.
    Immunotherapy (2016)

    Fulltext@MSK | Save